Stocktoria

Replimune Group, Inc. REPL

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-07-20 · LEI

Replimune Group, Inc. institutional holders

InvestorSharesValue% of company
BlackRock Finance, Inc.4,713,791$42.4M5.08%
AQR CAPITAL MANAGEMENT LLC2,566,241$28.4M2.77%
D. E. Shaw & Co., Inc.1,989,964$22.0M2.14%
CITADEL ADVISORS LLC1,928,233$21.3M2.08%
MILLENNIUM MANAGEMENT LLC990,458$11.0M1.07%
Point72 Asset Management, L.P.723,262$8.0M0.78%
TWO SIGMA INVESTMENTS, LP166,592$1.8M0.18%
RENAISSANCE TECHNOLOGIES LLC39,800$440,5860.04%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.